Skip to main content
Print Save

Ribavirin Capsules

Dosage form: capsule
Drug class: Inhaled anti-infectives, Purine nucleosides

Medically reviewed by Drugs.com. Last updated on Sep 1, 2020.

On This Page

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 65841-260-12 in bottle of 84 capsules

Ribavirin Capsules USP, 200 mg

Rx only

84 capsules

RIBAVIRIN
ribavirin capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:65841-260
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RIBAVIRIN (RIBAVIRIN) RIBAVIRIN 200 mg
Inactive Ingredients
Ingredient Name Strength
CROSPOVIDONE (15 MPA.S AT 5%)
MAGNESIUM STEARATE
GELATIN
POVIDONE
TITANIUM DIOXIDE
SILICON DIOXIDE
CELLULOSE, MICROCRYSTALLINE
Product Characteristics
Color WHITE (WHITE) Score no score
Shape CAPSULE (CAPSULE) Size 22mm
Flavor Imprint Code ZA;12;200mg
Contains
Packaging
# Item Code Package Description
1 NDC:65841-260-30 10 BLISTER PACK in 1 CARTON
1 10 CAPSULE in 1 BLISTER PACK
2 NDC:65841-260-04 42 CAPSULE in 1 BOTTLE
3 NDC:65841-260-07 56 CAPSULE in 1 BOTTLE
4 NDC:65841-260-09 70 CAPSULE in 1 BOTTLE
5 NDC:65841-260-12 84 CAPSULE in 1 BOTTLE
6 NDC:65841-260-13 140 CAPSULE in 1 BOTTLE
7 NDC:65841-260-03 168 CAPSULE in 1 BOTTLE
8 NDC:65841-260-28 180 CAPSULE in 1 BOTTLE
9 NDC:65841-260-10 1000 CAPSULE in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077224 01/25/2006
Labeler - Cadila Healthcare Limited (918596198)
Registrant - Cadila Healthcare Limited (918596198)
Establishment
Name Address ID/FEI Operations
Cadila Healthcare Limited 918596198 ANALYSIS(65841-260), MANUFACTURE(65841-260)
Cadila Healthcare Limited

Medical Disclaimer